Lung tumor immune cell study for surgery patients
Part of Cancer, Lungs & breathing clinical trials.
This study looks at immune cells inside lung tumors to better understand how they work. If you are having surgery for a thoracic tumor, your tissue could help researchers learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a thoracic (chest area) tumor that will be removed with surgery
- You have not had chemotherapy for any cancer in the last 6 months
- You are not pregnant or breastfeeding
- You are not currently taking medication that suppresses your immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at giving immunotherapy before surgery for certain early-stage lung cancers to help shrink the tumor and improve outcomes. It is mainly for people whose lung cancer can be removed by surgery and who don’t have specific gene changes like EGFR or ALK.
This study looks at molecular (biologic) signals in the tumor and nearby lymph nodes after curative surgery for stage IIIA lung cancer. It may help doctors better understand the disease and improve future treatment planning.
This study looks for biological markers (special signs in your body) that could help doctors choose better immune-based treatments for non-small cell lung cancer. Researchers will study your tumor and blood to understand which patients might benefit most from immunotherapy.
This study looks at a treatment plan that uses immunotherapy before and after surgery for non-small cell lung cancer. The goal is to see if this approach helps patients do better and to find out which patients benefit most.
This trial tests whether giving immunotherapy before surgery helps people with lung cancer. It is for patients who have already started this treatment and are otherwise healthy.
This study looks at tissue samples from people having surgery for lung cancer to learn about certain cells (MDSCs and cancer stem cells) that may affect how the cancer behaves. The goal is to understand these cells better, which could help improve treatments in the future.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.